lipophilic 1-cycloalkylamino-1-(pyrid-3-yl-sulfonamido)-2-nitr oethylenes were synthesized as bioisosteres of BM-34, an anticonvulsant sulfonylthiourea. Compound 17 (ip) emerged from the maximal electroshock seizure (MES) test with a 50% effective dose (ED50) of 8.25 mg/kg. Its anticonvulsant profile was similar to that of phenytoin (ED50 = 9.51 mg/kg) and of BM-34 (ED50 = 1.19 mg/kg): active in the MES test
合成了亲脂性的1-环烷基
氨基-1-(
吡啶-3-基-磺酰胺基)-2-
硝基乙烯,作为抗惊厥性磺酰
硫脲BM-34的
生物等排体。化合物17(ip)从最大电击惊厥(
MES)测试中出来,其50%有效剂量(ED50)为8.25 mg / kg。它的抗惊厥作用与
苯妥英钠(ED50 = 9.51 mg / kg)和BM-34(ED50 = 1.19 mg / kg)相似:在
MES试验中有效,而在皮下注射
戊四唑,苯丙
氨酸,双小分子碱引起的癫痫发作无效,微毒素或N-甲基-D,
L-天门冬氨酸 17的神经毒性(TD50 = 113.8 mg / kg)低于
苯妥英(TD50 = 65.5 mg / kg),但高于BM-34(TD50 = 147.2 mg / kg)。晶体学研究表明B
M-401(17)是两性离子结构。